![](/img/cover-not-exists.png)
PP 86 Immunohistochemistry and molecular biology of the PI3K pathway did not correlate with treatment efficacy of everolimus as second line or third line treatment of advanced endometrial carcinoma
O. Tredan, D. Pissaloux, I. Treilleux, Q. Wanq, N. Bonichon-Lamichhane, V. Mari, G. Freyer, E. Pujade-Lauraine, I. Ray-CoquardVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)72711-3
File:
PDF, 53 KB
english, 2011